Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Quantum Materials Corp and Nanoaxis Announce Technology Alliance: Biocompatible quantum dots to enable industrial scale production of Nanomedicines

Abstract:
Quantum Materials Corporation (www.qdotss.com) (Pink Sheets: QTMM) Quantum Materials Corp. and Nanoaxis, LLC announce the formation of a technology alliance combining Quantum Materials tetrapod quantum dot mass production technology with Nanoaxis advanced research expertise and intellectual property in gene therapy biomedical nanotechnology. The aim of the alliance is to develop Tetrapod Quantum Dot based Cancer diagnostic kits and theranostic applications including Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression.

Quantum Materials Corp and Nanoaxis Announce Technology Alliance: Biocompatible quantum dots to enable industrial scale production of Nanomedicines

Tempe, AZ | Posted on September 20th, 2011

Quantum Materials Corporation will develop specialized quantum dots for Nanoaxis to functionalize with their proprietary biomedical nanomaterials for a multiplexing drug delivery platform for drug/gene therapy and diagnostic medical devices technologies. The technology alliance allows these technologies to be developed rapidly due to Quantum Materials' ability to create the highest quality quantum dots in quantities necessary to support multiple projects with timely deliveries.

The immediate goal is to develop a QD microarray device for detection, diagnosis and quantification of early cancers. The QD-MI device will be designed for rapid detection and grading of various multiple cancers using blood assays, with higher accuracy and at less cost than current single ELISA assays. All diagnostic and pharmaceutical products will include QMC quantum dots functionalized by Nanoaxis biomedical IP nanotechnology.

According to a recent report published by BCC Research the total market for nanobiotechnology products is $19.3 billion in 2010 and is growing at a compound annual growth rate (CAGR) of 9% to reach a forecast market size of $29.7 billion by 2015.

Stephen Squires, CEO and President of Quantum Material Corporation and its subsidiary Solterra Renewable Resources, added, "This alliance will foster a breakthrough in theranostic science as it enables mass production of Nanoaxis nanomedicine product pipeline. The goal is to make these biologically adapted quantum dots the ideal choice for in vitro and in vivo applications for high throughput, efficient and cost effective applications in the biological and medical market spaces. Quantum Materials' ability to create tetrapod quantum dots of various materials, shapes, sizes and characteristics that can serve as delivery platforms for Nanoaxis products will allow for rapid commercial development."

"This is an exciting moment for our industry. We see this Technology Alliance between Nanoaxis and Quantum Materials Corp as bringing industrial scale production to the cutting edge of nanomedicine research. The synergy of the combined technologies is enhanced by the cooperation of our two companies' seasoned management and research teams and we believe this partnership will be the catalyst of many biomedicine advances," said Dr. Krishnan Chakravarthy, Nanoaxis, LLC President and CEO.

Siddhartha Kamisetti, Director of Global Strategy at Nanoaxis, commented, "This alliance opens the door for pioneering developments in the biomedical space and presents a significant opportunity to assist people suffering from a host of diseases and ailments throughout the world."

####

About Quantum Materials Corporation
QUANTUM MATERIALS CORPORATION has a steadfast vision that advanced technology is the solution to the most challenging of global issues. Quantum Materials Corporation is devoted to the deployment of technologies to invigorate the development of disruptive solutions through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products.

NANOAXIS' mission is to create nanomedicine products that make a bench-to-bedside paradigm shift and positively impact patient care. Nanoaxis is developing new therapies and diagnostics for detection, measurement and treatment of medical conditions and diseases including chronic pain, depression, Alzheimer's, cancer, diabetes and influenza.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that involve risks and uncertainties concerning our business products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov/ or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances

For more information, please click here

Contacts:
Quantum Materials Corp.
Mr. Richard Chancis
V.P. Business Dev.
305-773-7260


Nanoaxis, LLC.
Dr. Krishnan Chakravarthy
CEO


Siddhartha Kamisetti
Director of Global Strategy

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Timekeeping theory combines quantum clocks and Einstein's relativity: Research reveals new time dilation phenomenon October 23rd, 2020

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Cicada-inspired waterproof surfaces closer to reality, researchers report October 23rd, 2020

Trailblazing theoretical physicist Sylvester James Gates Jr. is among speakers at nanotechnology symposium: Annual event moves to virtual format, open to attendees worldwide at no charge Oct. 29 October 23rd, 2020

Nanomedicine

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

Controlling the speed of enzyme motors brings biomedical applications of nanorobots closer: Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems October 13th, 2020

New drug carrier systems: University of Delaware researchers advance drug delivery systems to treat connective tissue disorders October 9th, 2020

Announcements

Timekeeping theory combines quantum clocks and Einstein's relativity: Research reveals new time dilation phenomenon October 23rd, 2020

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Cicada-inspired waterproof surfaces closer to reality, researchers report October 23rd, 2020

Trailblazing theoretical physicist Sylvester James Gates Jr. is among speakers at nanotechnology symposium: Annual event moves to virtual format, open to attendees worldwide at no charge Oct. 29 October 23rd, 2020

Patents/IP/Tech Transfer/Licensing

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

The Wave of the Future: Researchers achieve first successful generation and detection of pure spin currents in antiferromagnetic materials January 29th, 2020

Industrial

A quantum material-based diagnostic paint to sense problems before structural failure October 23rd, 2020

GLOBALFOUNDRIES Announces Industry-Leading GF SHIELD Program to Further Safeguard Customer Data and IP: GF embraces experience of manufacturing the world’s most secure semiconductor solutions for the defense and aerospace industry, and extends these world-class security capabilit October 1st, 2020

An improved wearable, stretchable gas sensor using nanocomposites August 28th, 2020

Bosch launches longevity program for industrial and IoT applications: High-performance accelerometer, IMU and pressure sensor with 10-year availability July 23rd, 2020

Quantum Dots/Rods

A quantum material-based diagnostic paint to sense problems before structural failure October 23rd, 2020

Turning a hot spot into a cold spot: Fano-shaped local-field responses probed by a quantum dot October 9th, 2020

Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020

UTEP researchers help bring biofriendly materials to drug design for neuro disorders June 5th, 2020

Alliances/Trade associations/Partnerships/Distributorships

Deca Partners with ADTEC Engineering to Enhance Adaptive Patterning™ for 2µm Chiplet Scaling October 20th, 2020

GLOBALFOUNDRIES and Mentor Collaborate to Launch New Semiconductor Verification Solution Embedded with Advanced Machine Learning Capabilities: New industry-leading ML-enhanced DFM solution for designing on GF 12LP+ platform can provide customers with a more efficient experience October 1st, 2020

GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology: Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime October 1st, 2020

The ICN2 co-leads a roadmap on quantum materials September 29th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project